Menu

Image of the Day: Release Your Inhibitions

A drug commonly used to treat clinical depression sets its effects in motion by hampering the release of an inhibitory neurotransmitter in mice.

Jul 31, 2017
The Scientist Staff

In the mouse dentate gyrus, cholecystokinin neurons (red) and a protein they produce (p11; green) that's critical for initiating a response to selective serotonin reuptake inhibitors LABORATORY OF MOLECULAR AND CELLULAR NEUROSCIENCE AT THE ROCKEFELLER UNIVERSITY/NEURON Selective serotonin reuptake inhibitors (SSRIs) are drugs used to manage depressive disorders, but their precise mode of action is elusive. Researchers recently demonstrated that SSRIs target certain receptors on cholecystokinin neurons in the mouse hippocampus and prevent them from releasing inhibitory neurotransmitters, the first steps in a longer cascade.

See L. Medrihan et al., “Initiation of Behavioral Response to Antidepressants by Cholecystokinin Neurons of the Dentate Gyrus,” Neuron, 95:1-13, 2017.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.
Corning Introduces New 1536-well Spheroid Microplate
Corning Introduces New 1536-well Spheroid Microplate
High-throughput spheroid microplate benefits cancer research, drug screening